Specific features of current intraperitoneal therapy in patients with ovarian cancer

Specific features of current intraperitoneal therapy in patients with ovarian cancer

Background. Today there are 3 trends in favor of intraperitoneal (IP) chemotherapy: maintenance of its potential 5- and 10-year survival benefit in patients with ovarian cancer (OC); advantages of the IP administration of drugs even after nonoptimal surgery; enhancement of the efficiency of chemothe...

Full description

Bibliographic Details
Main Authors: A. G. Kedrova, S. A. Levakov, S. E. Krasil’nikov, T. A. Maksimenko, V. I. Voznesenskiy, A. V. Gerasimov, D. A. Astakhov, V. V. Kosyy, O. E. Nechaeva
Format: Article
Language:Russian
Published: ABV-press 2016-06-01
Series:Опухоли женской репродуктивной системы
Subjects:
ovarian cancer
intraperitoneal metastases
intraperitoneal chemotherapy
optimal cytoreductive surgery
high-grade serous ovarian adenocarcinoma
low-grade serous ovarian adenocarcinoma
cisplatin
paclitaxel
celsite® port systems
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/482

Internet

https://ojrs.abvpress.ru/ojrs/article/view/482

Similar Items